(Reuters) -Laboratory operator Labcorp beat analysts' estimate for first ... the critical nature of the work we do in diagnostics and drug development positions us well for success in 2025 and ...

The yet-to-be-named new company will be publicly traded. Separating the laboratory testing work of LabCorp from the clinical trial services business, much of which came from acquisitions, will ...

Labcorp is now offering a blood-based biomarker test in the U.S. to support the diagnosis ... assays and PET imaging cleared by the Food and Drug Administration. The sensitivity and specificity ...

Labcorp provides at-home test kits as well as in-person testing at their laboratory facilities, which are located in 47 states throughout the United States. As of this writing, Labcorp manages 36 ...

the first over-the-counter blood test granted market authorization by the U.S. Food & Drug Administration (FDA) that can be performed by both physicians and patients. Labcorp will serve as the ...

The new test is part of Labcorp's ongoing efforts to support healthcare ... has played a significant role in diagnostics and drug development, supporting a substantial percentage of FDA-approved ...

A few websites can be used to order this test and numerous other ... or Labcorp OnDemand (ondemand.labcorp.com). The ALPACA trial showed that the experimental drug lepodisiran can lower this ...